[HTML][HTML] Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
AMJ Shapiro, JRT Lakey, EA Ryan… - … England Journal of …, 2000 - Mass Medical Soc
Background Registry data on patients with type 1 diabetes mellitus who undergo pancreatic
islet transplantation indicate that only 8 percent are free of the need for insulin therapy at …
islet transplantation indicate that only 8 percent are free of the need for insulin therapy at …
[HTML][HTML] International trial of the Edmonton protocol for islet transplantation
…, E Cagliero, R Alejandro, EA Ryan… - … England Journal of …, 2006 - Mass Medical Soc
Background Islet transplantation offers the potential to improve glycemic control in a subgroup
of patients with type 1 diabetes mellitus who are disabled by refractory hypoglycemia. We …
of patients with type 1 diabetes mellitus who are disabled by refractory hypoglycemia. We …
Five-year follow-up after clinical islet transplantation
Islet transplantation can restore endogenous β-cell function to subjects with type 1 diabetes.
Sixty-five patients received an islet transplant in Edmonton as of 1 November 2004. Their …
Sixty-five patients received an islet transplant in Edmonton as of 1 November 2004. Their …
Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol
Islet transplantation offers the prospect of good glycemic control without major surgical risks.
After our initial report of successful islet transplantation, we now provide further data on 12 …
After our initial report of successful islet transplantation, we now provide further data on 12 …
Successful islet transplantation: continued insulin reserve provides long-term glycemic control
EA Ryan, JRT Lakey, BW Paty, S Imes, GS Korbutt… - Diabetes, 2002 - Am Diabetes Assoc
Clinical islet transplantation is gaining acceptance as a potential therapy, particularly for
subjects who have labile diabetes or problems with hypoglycemic awareness. The risks of the …
subjects who have labile diabetes or problems with hypoglycemic awareness. The risks of the …
The efficacy of acarbose in the treatment of patients with non–insulin-dependent diabetes mellitus: A multicenter, controlled clinical trial
…, NW Rodger, SA Ross, EA Ryan… - Annals of internal …, 1994 - acpjournals.org
Objective: To evaluate the long-term efficacy of acarbose, an α-glucosidase inhibitor, in
improving glycemic control in patients with non–insulin-dependent diabetes mellitus. Design: A 1-…
improving glycemic control in patients with non–insulin-dependent diabetes mellitus. Design: A 1-…
Role of gestational hormones in the induction of insulin resistance
EA RYAN, L ENNS - The Journal of Clinical Endocrinology & …, 1988 - academic.oup.com
Pregnancy is associated with insulin resistance. We studied insulin binding and postbinding
function in isolated adipocytes from pregnant and nonpregnant rats. We also used a primary …
function in isolated adipocytes from pregnant and nonpregnant rats. We also used a primary …
Insulin action during pregnancy: studies with the euglycemic clamp technique
EA Ryan, MJ O'Sullivan, JS Skyler - Diabetes, 1985 - Am Diabetes Assoc
To assess the mechanisms responsible for the insulin resistance associated with both normal
human pregnancy and gestational-onset diabetes, we have measured exogenous glucose …
human pregnancy and gestational-onset diabetes, we have measured exogenous glucose …
Short-term intensive insulin therapy in newly diagnosed type 2 diabetes
EA Ryan, S Imes, C Wallace - Diabetes care, 2004 - Am Diabetes Assoc
OBJECTIVE—Type 2 diabetes is associated with defects in insulin secretion and insulin
action. Hyperglycemia may aggravate these defects, a feature known as glucose toxicity. …
action. Hyperglycemia may aggravate these defects, a feature known as glucose toxicity. …
[HTML][HTML] The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on …
…, R Rabasa-Lhoret, NW Rodger, EA Ryan - The American journal of …, 2008 - Elsevier
Background The optimal source and amount of dietary carbohydrate for managing type 2
diabetes (T2DM) are unknown. Objective We aimed to compare the effects of altering the …
diabetes (T2DM) are unknown. Objective We aimed to compare the effects of altering the …